Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Di Gennaro
Observed names:
Di Gennaro, Francesca,
F Di Gennaro,
F. Di Gennaro,
FRANCESCA DI GENNARO
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Federico II University Hospital,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Naples Federico II
ORCID:
0000-0003-1196-7842
Observed ORCID:
0000-0003-1196-7842
OpenAlex ID:
A5076486369
Different patterns of technetium-99m sestamibi uptake in multiple myeloma
1998
·
Leonardo Pace
, Lucio Catalano
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
87
Role of 68Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)
2015
·
Secondo Lastoria
, Francesca Marciello
, et al.
·
Endocrine
·
64
Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome
2012
·
Antonio Avallone
, Luigi Aloj
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
62
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma
2001
·
R. Fonti
, S. Del Vecchio
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
53
Targeted therapy: A new hope for thyroid carcinomas
2014
·
Francesco Perri
, Luciano Pezzullo
, et al.
·
Critical Reviews in Oncology/Hematology
·
47
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
2014
·
Luigi Aloj
, Laura D’Ambrosio
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
38
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
2019
·
Francesca Collina
, Lucia La Sala
, et al.
·
Cancers
·
36
PDF
Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up
2001
·
Leonardo Pace
, Lucio Catalano
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
34
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
1999
·
L Catalano
, L Pace
, et al.
·
PubMed
·
32
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer
2019
·
Antonio Avallone
, Luigi Aloj
, et al.
·
Journal of Nuclear Medicine
·
31
PDF
Scintimammography with 99mTc-MIBI versus dynamic MRI for non-invasive characterization of breast masses
2000
·
Massimo Imbriaco
, Silvana Del Vecchio
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
31
Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
2022
·
Costantina Maisto
, Michela Aurilio
, et al.
·
Molecules
·
29
PDF
Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
2023
·
Antonella Lucia Marretta
, Alessandro Ottaiano
, et al.
·
Journal of Clinical Medicine
·
25
PDF
Diagnostic imaging of parotid gland oncocytoma: a pictorial review with emphasis on ultrasound assessment
2020
·
Antonio Corvino
, Martina Caruso
, et al.
·
Journal of Ultrasound
·
24
PDF
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives
2024
·
Alessandra Bracigliano
, Antonella Lucia Marretta
, et al.
·
Pharmaceuticals
·
20
PDF
A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practice
2023
·
Valentina Pirozzi Palmese
, Laura D’Ambrosio
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
18
PDF
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm
2021
·
Vincenzo Marotta
, Maria Grazia Chiofalo
, et al.
·
Critical Reviews in Oncology/Hematology
·
17
Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome
2018
·
Maria Grazia Chiofalo
, Raffaella D’Anna
, et al.
·
Endocrine
·
16
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life
2024
·
Vincenzo Marotta
, Domenico Rocco
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
15
Combined Papillary and Mucoepidermoid Carcinoma of the Thyroid Gland: a Possible Collision Tumor Diagnosed on Fine-Needle Cytology. Report of a Case with Immunocytochemical and Molecular Correlations
2015
·
Franco Fulciniti
, Emilia Vuttariello
, et al.
·
Endocrine Pathology
·
14
Follicular thyroid carcinoma with skull metastases
2015
·
Maria Grazia Chiofalo
, Sergio Venanzio Setola
, et al.
·
Endocrine Journal
·
9
PDF
Preliminary evaluation of radioimmunotherapy with Tenarad, a I-131 labeled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin lymphoma.
2011
·
L. Aloj
, L. D'Ambrosio
, et al.
·
Journal of Clinical Oncology
·
5
Oligometastatic prostate cancer treatment
2021
·
Sabrina Rossetti
, Marilena Di Napoli
, et al.
·
Future Oncology
·
4
Tc-99m Sestamibi Scintigraphy in Multiple Myeloma
1999
·
FRANCESCA DI GENNARO
, LUCIO CATALANO
, et al.
·
Clinical Nuclear Medicine
·
4
First-line lenvatinib and sorafenib in RR-DTC from a shared real-life context
2025
·
Vincenzo Marotta
, Anna Tortora
, et al.
·
Endocrine Related Cancer
·
3
Show more works
View as search
Works count:
37
Citation count:
720
H-index:
17
I10-index:
20
Year
Topic
Type